Skip to content

Vera Therapeutics VERA Change in Lease Liabilities

Change in Lease Liabilities at other companies

Alumis Inc. logo
Alumis Inc.ALMS
-$1.25M-102%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-$3.19M-17.8%
TG Therapeutics logo
TG TherapeuticsTGTX
-$424K+21.9%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's change in lease liabilities?
Vera Therapeutics (VERA) reported change in lease liabilities of -$182K in Q1 2026.
How has Vera Therapeutics's change in lease liabilities changed year-over-year?
Vera Therapeutics's change in lease liabilities increased by 53.8% year-over-year, from -$394K to -$182K.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.